The German Federal Ministry of Research, Technology and Space (BMFTR) is calling for funding for translational projects on cancer metabolism within the framework of the EU network TRANSCAN-4. The guideline, entitled “Translational Research on Cancer Metabolism: Multidisciplinary Approaches to Diagnosis and Treatment”, was published in the Federal Gazette on 5 June 2026.

The aim of the funding measure is to strengthen international research networks and to bring the understanding of metabolic changes in cancer into clinical application. The focus is on the development of new biomarkers for diagnosis and monitoring as well as the use of metabolic vulnerabilities for improved precision medicine. The projects are intended to advance innovative, personalized approaches to diagnosis, patient stratification and therapy.

The call is part of the first joint transnational call (JTC-2026) of TRANSCAN-4. Funding organisations from Germany, Austria, Belgium, Canada, France, Hungary, Israel, Italy, Malta, Poland, Romania, Slovakia, Spain, Taiwan and Turkey are involved.

Interdisciplinary cooperation projects with high translational potential that must be of clinical relevance are funded. Pure preclinical studies with established cell lines as well as clinical trials of phases III and IV are not eligible for funding. The announcement is based on the Federal Government’s Health Research Framework Programme.

Interested parties can view further details on the TRANSCAN website (transcan.eu) and at the BMFTR. Funding is provided in accordance with national guidelines for the respective project shares.

Original Paper:

Homepage – Announcement – BMFTR

Editor: X-Press Journalistenbüro GbR

Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability ected.